1. Deciphering Alzheimer's.
Our groundbreaking Alzheimer research focuses on exploring marine biotechnological solutions to combat neurodegenerative diseases. Specifically, we investigate seaweed-derived compounds for their potential to inhibit amyloid-beta plaque formation, a key factor in Alzheimer's progression. By leveraging the unique properties of these marine resources, our research aims to develop innovative treatments that could slow or even prevent the onset of Alzheimer's disease. This project not only enhances our understanding of the disease but also opens new avenues for effective and sustainable medical interventions.
2. Seaweed Therapy: Tackling LOAD.
This second running project entitled: “Seaweed Therapy: Tackling LOAD”, aims to evaluate the potential of seaweed therapy in mitigating the by “Lancet December 2022 projection study” (Lancet Public Health, 2022) around 2050 “Late Onset Alzheimer’s Disease” (LOAD) pandemics, focusing on its rich nutritional profile, including ω-3 ‘Very Long-Chain Polyunsaturated Fatty Acids’ (VLC-PUFAs) and essential vitamins. By promoting affordable, accessible nutritional supplementation in ‘low- and middle-income countries’ (LMICs), we seek to prevent and treat Alzheimer’s Disease, countering the limitations of the traditional “Amyloid-β protein cascade hypothesis” and focus on the “Nutritional deficiency hypothesis” of AD.
